Citadel Advisors - INTRA CELLULAR THERAPIES INC ownership

Back to all holdings Add to watchlist

INTRA CELLULAR THERAPIES INC's ticker is and the CUSIP is 46116X901. A total of 4 filers reported holding INTRA CELLULAR THERAPIES INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Citadel Advisors ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q2 2016$873,000
+350.0%
22,500
+525.0%
0.00%–
Q4 2015$194,000
-64.9%
3,600
-73.9%
0.00%
-100.0%
Q3 2015$553,000
+2413.6%
13,800
+1871.4%
0.00%–
Q2 2015$22,000–700–0.00%–
 Download
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q3 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 43,500$2,355,5250.01%
JANE STREET GROUP, LLC 180,500$9,774,0750.00%
SIMPLEX TRADING, LLC 57,000$3,0860.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INTRA CELLULAR THERAPIES INC shareholders